The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy

scientific article published on 27 May 2015

The use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00432-015-1991-5
P698PubMed publication ID26013424

P50authorGerald AntochQ110980843
P2093author name stringNikolaus Becker
Peter Albers
Helmut E Gabbert
Robert Rabenalt
Christian Arsov
Michael Quentin
Frederic Dietzel
Lars Schimmöller
Andreas Hiester
P2860cites workMagnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy.Q45967722
Association between percentage of tumor involvement and Gleason score upgrading in low-risk prostate cancerQ47635662
Radiotherapy and short-term androgen deprivation for localized prostate cancer.Q51021354
Prostate needle biopsies: interobserver variation and clinical consequences of histopathological re-evaluation.Q51578950
Improving detection of clinically significant prostate cancer: magnetic resonance imaging/transrectal ultrasound fusion guided prostate biopsy.Q53304507
Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy--should we reassess our practices for antibiotic prophylaxis?Q54351950
A biopsy simulation study to assess the accuracy of several transrectal ultrasonography (TRUS)-biopsy strategies compared with template prostate mapping biopsies in patients who have undergone radical prostatectomyQ63966214
Role of magnetic resonance imaging before initial biopsy: comparison of magnetic resonance imaging-targeted and systematic biopsy for significant prostate cancer detectionQ63966218
Prognostic factors in men with stage D1 prostate cancer: identification of patients less likely to have prolonged survival after radical prostatectomy.Q64966358
Prostate biopsy grading errors: a sampling problem?Q73444033
Assessment of clinical and pathologic characteristics predisposing to disease recurrence following radical prostatectomy in men with pathologically organ-confined prostate cancerQ74325627
Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysisQ81036362
Predictors of prostate cancer-specific mortality after radical prostatectomy or radiation therapyQ81280205
Impact of a tertiary Gleason pattern 4 or 5 on clinical failure and mortality after radical prostatectomy for clinically localised prostate cancerQ84967080
Prospective evaluation of magnetic resonance imaging guided in-bore prostate biopsy versus systematic transrectal ultrasound guided prostate biopsy in biopsy naïve men with elevated prostate specific antigenQ87965125
ESUR prostate MR guidelines 2012Q24620926
The role of magnetic resonance imaging in the diagnosis and management of prostate cancerQ26849794
Magnetic resonance imaging-ultrasound fusion biopsy for prediction of final prostate pathologyQ34364108
Gleason grading of prostate cancer: level of concordance between pathologists at the University Hospital of the West IndiesQ35885016
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic CarcinomaQ36227180
The potential impact of reproducibility of Gleason grading in men with early stage prostate cancer managed by active surveillance: a multi-institutional studyQ37890605
Active surveillance for prostate cancer: a systematic review of the literatureQ38018748
EAU guidelines on prostate cancer. part 1: screening, diagnosis, and local treatment with curative intent-update 2013.Q38160994
Low-risk prostate cancer: the accuracy of multiparametric MR imaging for detectionQ38183902
Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trialQ38392753
Morbidity after transperineal prostate biopsy in 3000 patients undergoing 12 vs 18 vs more than 24 needle coresQ40114797
Predicting extracapsular extension of prostate cancer in men treated with radical prostatectomy: results from the population based prostate cancer outcomes studyQ41691247
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.Q43467766
A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trialQ43493324
MR-sequences for prostate cancer diagnostics: validation based on the PI-RADS scoring system and targeted MR-guided in-bore biopsyQ44119084
25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution seriesQ44921443
Targeted MRI-guided prostate biopsies for the detection of prostate cancer: initial clinical experience with real-time 3-dimensional transrectal ultrasound guidance and magnetic resonance/transrectal ultrasound image fusionQ44944586
Presence of high grade tertiary Gleason pattern upgrades the Gleason sum score and is inversely associated with biochemical recurrence-free survival.Q45412507
P433issue11
P407language of work or nameEnglishQ1860
P304page(s)2061-2068
P577publication date2015-05-27
P1433published inJournal of Cancer Research and Clinical OncologyQ2081599
P1476titleThe use of targeted MR-guided prostate biopsy reduces the risk of Gleason upgrading on radical prostatectomy
P478volume141

Reverse relations

cites work (P2860)
Q501049691.0T MR-guided percutaneous coaxial cutting needle biopsy in pancreatic lesion diagnosis
Q52674710Can Prostate Imaging Reporting and Data System Version 2 reduce unnecessary prostate biopsies in men with PSA levels of 4-10 ng/ml?
Q57493742Comparison of Gleason upgrading rates in transrectal ultrasound systematic random biopsies versus US-MRI fusion biopsies for prostate cancer
Q95261579Evolution of prostate cancer diagnosis: retrospective analysis of magnetic resonance imaging/ultrasound fusion guided biopsies protocol in routine practice and patients management
Q48025252External validation and comparison of two nomograms predicting the probability of Gleason sum upgrading between biopsy and radical prostatectomy pathology in two patient populations: a retrospective cohort study
Q57725405How Would MRI-targeted Prostate Biopsy Alter Radiation Therapy Approaches in Treating Prostate Cancer?
Q60923446Imaging as a Personalized Biomarker for Prostate Cancer Risk Stratification
Q57111662Impact of multiparametric MRI and MRI-targeted biopsy on pre-therapeutic risk assessment in prostate cancer patients candidate for radical prostatectomy
Q51471939MR-guided percutaneous biopsy of solitary pulmonary lesions using a 1.0-T open high-field MRI scanner with respiratory gating.
Q96813857Pathological findings at radical prostatectomy of biopsy naïve men diagnosed with MRI targeted biopsy alone without concomitant standard systematic sampling
Q40463189Preoperative low serum testosterone is associated with high-grade prostate cancer and an increased Gleason score upgrading.
Q38779933Recent advances in prostate cancer pathology: Gleason grading and beyond
Q57493779Risk of upgrading from prostate biopsy to radical prostatectomy pathology: Is magnetic resonance imaging-guided biopsy more accurate?
Q53630425Targeted MRI-guided prostate biopsy: are two biopsy cores per MRI-lesion required?
Q50088856The Current State of MR Imaging-targeted Biopsy Techniques for Detection of Prostate Cancer.
Q38795731Use of mpMRI in active surveillance for localized prostate cancer
Q33580964Utilization of multiparametric prostate magnetic resonance imaging in clinical practice and focal therapy: report from a Delphi consensus project